CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for PZ Wind Down Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

PZ Wind Down Inc
410 W Harrison St Ste 300
Phone: (206) 805-6300p:206 805-6300 SEATTLE, WA  98119-4034  United States Ticker: PZRXQPZRXQ
This entity represents the bankrupt estate of the former business (assets) of PhaseRx Inc. that was not sold to Roivant Sciences GmbH on 2/2/2018.
Business Summary
Pz Wind Down, Inc., formerly, PhaseRx, Inc. is a biopharmaceutical company developing a portfolio of mRNA products to correct life-threatening inherited liver diseases in children. The Company's initial product development focus is on urea cycle disorders, a group of rare genetic diseases that generally present before the age of 12 and are characterized by the body's inability to remove ammonia from the blood. The Company's i-ERT approach is enabled by its Hybrid mRNA Technology platform and is applicable to a number of inherited liver diseases.
(Source: PRESS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/201712/31/2016YesYesYes--

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board StevenGillis 1/1/2008 1/1/2008
President, Chief Executive Officer, Principal Accounting Officer, Secretary, Director Robert W.Overell 62 9/25/2017 1/1/2006
Vice President - Chemistry SeanMonahan 1/1/2015 7/1/2009
7 additional Officers and Directors records available in full report.

Business Names
Business Name
PhaseRx Ireland Limited
PZRX
PZRXQ

General Information
Number of Employees: 15 (As of 3/31/2016)
Outstanding Shares: 11,690,329 (As of 11/3/2017)
Stock Exchange: OTC
Federal Tax Id: 204690620
Fax Number: (302) 636-5454


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 29, 2023